Gastrointestinal Endoscopic Device Market Report Suite - China - 2020-2026 - MedSuite

Throughout this medical market research, the publisher analyzed 43 endoscopic device companies in China and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuite report contains all of the Chinese Gastrointestinal Endoscopic Devices market analysis, each of the market segments is also available as stand-alone MedCore reports. Additionally, this research includes a gastrointestinal endoscopy procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered

• Gastrointestinal Endoscopy Procedure Volumes in China – MedPro
• Gastrointestinal Endoscope Market - MedCore
• Capsule Endoscopy Market - MedCore
• Stenting & Dilation Market - MedCore
• Endoscopic Retrograde Cholangiopancreatography (ERCP) Market - MedCore
• Endoscopic Tissue Sampling Device (ETSD) Market - MedCore
• Hemostasis Device Market - MedCore

Chinese Gastrointestinal Endoscopic Devices Market Insights

Growth of the Chinese gastrointestinal endoscopic device market will likely be limited by the prevalence of government hospitals. Since government hospitals dominate the GI treatment space, their purchasing decisions have large impacts on ASPs. Government hospitals tend to buy in bulk, which is often associated with discounted deals, depressing ASPs in the GI space.

As endoscopy represents a major segment of the Chinese market, technological improvements to these devices will propel growth of the total GI market moving forward. The HD format, and now HD+, along with advanced magnification capabilities, which penetrated the GI endoscope market only recently, resulted in a greater detection rate for polyps.

Overall, the Chinese gastrointestinal endoscopic device market was valued at approximately $1.3 billion in 2019. This is expected to increase over the forecast period at a CAGR of 5.1% to approach $1.9 billion.